Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). I. Physiology, pharmacology and pathophysiological implications
- 1 September 1990
- journal article
- review article
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 10 (5) , 407-426
- https://doi.org/10.1111/j.1475-097x.1990.tb00822.x
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- L-arginine availability determines the duration of acetylcholine-induced systemic vasodilatation in vivoBiochemical and Biophysical Research Communications, 1989
- L-Arginine is a precursor for nitrate biosynthesis in humansBiochemical and Biophysical Research Communications, 1989
- Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxideBiochemical and Biophysical Research Communications, 1989
- A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Vascular activity of polycations and basic amino acids: L-arginine does not specifically elicit endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1989
- Endothelium modulates the effects of α-adrenoceptor agonists in vascular smooth muscleGeneral Pharmacology: The Vascular System, 1988
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Determination of immunoreactive somatostatin in rat plasma and responses to arginine, glucose and glucagon infusionDiabetologia, 1979
- Activation of cerebral guanylate cyclase by nitric oxideBiochemical and Biophysical Research Communications, 1977